{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:59:32Z","timestamp":1759010372249},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:00:00Z","timestamp":1235001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,8]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Although pituitary hormones are known to affect immune function, treated hypopituitarism is not a recognized cause of immune deficiency in humans. We set out to assess integrity of baseline and stimulated immune function in severely hypopituitary adults. Twenty-one panhypopituitary adults (group 1), on stable pituitary replacement including growth hormone, and 12 healthy volunteers (group 2) were studied. Lymphocyte subsets, pneumococcal antibody levels pre- and 1 month after polysaccharide vaccination, T cell numbers and in-vitro interferon (IFN)-\u03b3 response were studied. There were no significant differences in T cell numbers or IFN-\u03b3 secretion. B cell numbers were lower in group 1, especially those with low prolactin levels. Independent of this finding, nine of 21 patients in this group had low antibody response to polysaccharide antigen. This was most striking in those with low insulin-like growth factor 1 levels and appeared to be independent of the use of anti-convulsants or corticosteroid replacement. Significant humoral immune deficiency is seen in panhypopituitarism and may contribute to morbidity.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2009.03881.x","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T14:20:32Z","timestamp":1235053232000},"page":"271-277","source":"Crossref","is-referenced-by-count":10,"title":["Failure of antibody response to polysaccharide antigen in treated panhypopituitary adults"],"prefix":"10.1093","volume":"156","author":[{"given":"A","family":"Mukherjee","sequence":"first","affiliation":[{"name":"Departments of Endocrinology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Helbert","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W D J","family":"Ryder","sequence":"additional","affiliation":[{"name":"Medical Statistics, Christie Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Borrow","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Unit, Health Protection Agency, Manchester Royal Infirmary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J R E","family":"Davis","sequence":"additional","affiliation":[{"name":"Endocrine Sciences Research Group, University of Manchester, Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S M","family":"Shalet","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,2,19]]},"reference":[{"key":"2021122708534466800_b1","first-page":"145","article-title":"Hypopituitarism following external radiotherapy for pituitary tumours in adults","volume":"70","author":"Littley","year":"1989","journal-title":"Q J Med"},{"key":"2021122708534466800_b2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJM199301143280203","article-title":"Hypothalamic\u2013pituitary dysfunction after radiation for brain tumors","volume":"328","author":"Constine","year":"1993","journal-title":"N Engl J Med"},{"key":"2021122708534466800_b3","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1210\/jc.2002-021741","article-title":"Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders","volume":"88","author":"Mukherjee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122708534466800_b4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/edrv.19.2.0329","article-title":"The diagnosis of growth hormone deficiency in children and adults","volume":"19","author":"Shalet","year":"1998","journal-title":"Endocr Rev"},{"key":"2021122708534466800_b5","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1210\/jc.2005-2491","article-title":"Prolactin deficiency is independently associated with reduced insulin-like growth factor I status in severely growth hormone-deficient adults","volume":"91","author":"Mukherjee","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122708534466800_b6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-2007-978759","article-title":"Expression of growth hormone and insulin-like growth factor in the immune system of children","volume":"31","author":"Yang","year":"1999","journal-title":"Horm Metab Res"},{"key":"2021122708534466800_b7","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1210\/endo.134.5.8156910","article-title":"Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry","volume":"134","author":"Dardenne","year":"1994","journal-title":"Endocrinology"},{"key":"2021122708534466800_b8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clim.2005.03.013","article-title":"Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes","volume":"116","author":"Chavez-Rueda","year":"2005","journal-title":"Clin Immunol"},{"key":"2021122708534466800_b9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF03343975","article-title":"Lymphocyte subset pattern in acromegaly","volume":"25","author":"Colao","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"2021122708534466800_b10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1677\/joe.0.1690429","article-title":"Neuroendocrine regulation of autoimmune\/inflammatory disease","volume":"169","author":"Sternberg","year":"2001","journal-title":"J Endocrinol"},{"key":"2021122708534466800_b11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nri1810","article-title":"Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens","volume":"6","author":"Sternberg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2021122708534466800_b12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1365-2265.2003.01916.x","article-title":"Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic\u2013pituitary (HP) axis","volume":"59","author":"Mukherjee","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122708534466800_b13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2265.2004.02004.x","article-title":"Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status","volume":"60","author":"Mukherjee","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122708534466800_b14","first-page":"53","article-title":"Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study","volume":"60","author":"Brabant","year":"2003","journal-title":"Horm Res"},{"key":"2021122708534466800_b15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/jcp.53.3.177","article-title":"Benign monoclonal expansion of CD8+ lymphocytes in HIV infection","volume":"53","author":"Smith","year":"2000","journal-title":"J Clin Pathol"},{"key":"2021122708534466800_b16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jim.2004.11.006","article-title":"Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes","volume":"296","author":"Lal","year":"2005","journal-title":"J Immunol Methods"},{"key":"2021122708534466800_b17","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1128\/CVI.00264-07","article-title":"Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine","volume":"14","author":"Balmer","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"2021122708534466800_b18","first-page":"6","article-title":"Invasive pneumococcal infection in England and Wales 1999","volume":"11","author":"George","year":"2001","journal-title":"CDR Wkly"},{"key":"2021122708534466800_b19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1365-2249.2003.02232.x","article-title":"Measurement and interpretation of pneumococcal IgG levels for clinical management","volume":"133","author":"Balmer","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2021122708534466800_b20","first-page":"289","article-title":"Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma. Recurrent infection, chronic diarrhea, and failure to thrive in a seven-month-old infant","volume":"70","author":"Lahood","year":"1993","journal-title":"Ann Allergy"},{"key":"2021122708534466800_b21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.rmed.2004.04.012","article-title":"Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids","volume":"98","author":"De Roux","year":"2004","journal-title":"Respir Med"},{"key":"2021122708534466800_b22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","article-title":"Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis","volume":"45","author":"Kapetanovic","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2021122708534466800_b23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/107999001750133159","article-title":"Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines","volume":"21","author":"Agarwal","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"2021122708534466800_b24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0090-1229(83)90193-9","article-title":"Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes","volume":"28","author":"Bast","year":"1983","journal-title":"Clin Immunol Immunopathol"},{"key":"2021122708534466800_b25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2249.2003.02097.x","article-title":"Immunoglobulins in children with epilepsy: the Dutch study of epilepsy in childhood","volume":"131","author":"Callenbach","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2021122708534466800_b26","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy adults by tetanus and TBE vaccines","volume":"9","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"key":"2021122708534466800_b27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"2021122708534466800_b28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"2021122708534466800_b29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism","volume":"46","author":"Bulow","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2021122708534466800_b30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/acta.0.1020351","article-title":"Regulation of immunity in rats by lactogenic and growth hormones","volume":"102","author":"Nagy","year":"1983","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2021122708534466800_b31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000097168","article-title":"The role of the growth and lactogenic hormone family in immune function","volume":"1","author":"Berczi","year":"1994","journal-title":"Neuroimmunomodulation"},{"key":"2021122708534466800_b32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/edrv.18.2.0296","article-title":"The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function","volume":"18","author":"Clark","year":"1997","journal-title":"Endocr Rev"},{"key":"2021122708534466800_b33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0165-5728(00)00303-9","article-title":"Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function","volume":"109","author":"Richards","year":"2000","journal-title":"J Neuroimmunol"},{"key":"2021122708534466800_b34","first-page":"292","article-title":"The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency","volume":"21","author":"Dorshkind","year":"2000","journal-title":"Endocr Rev"},{"key":"2021122708534466800_b35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1210\/rp.57.1.435","article-title":"Prolactin modulation of immune and inflammatory responses","volume":"57","author":"Yu-Lee","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"2021122708534466800_b36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1477-7827-2-51","article-title":"The prolactin and growth hormone families: pregnancy-specific hormones\/cytokines at the maternal-fetal interface","volume":"2","author":"Soares","year":"2004","journal-title":"Reprod Biol Endocrinol"},{"key":"2021122708534466800_b37","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/bies.20468","article-title":"Prolactin in man: a tale of two promoters","volume":"28","author":"Gerlo","year":"2006","journal-title":"BioEssays"},{"key":"2021122708534466800_b38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1568-9972(02)00081-2","article-title":"Prolactin and autoimmunity","volume":"1","author":"Vera-Lastra","year":"2002","journal-title":"Autoimmun Rev"},{"key":"2021122708534466800_b39","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/art.11105","article-title":"Sex hormones and systemic lupus erythematosus: review and meta-analysis","volume":"48","author":"McMurray","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2021122708534466800_b40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11102-005-5082-5","article-title":"Prolactin and autoimmunity","volume":"8","author":"De Bellis","year":"2005","journal-title":"Pituitary"},{"key":"2021122708534466800_b41","first-page":"1514","article-title":"Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays","volume":"34","author":"Cardenas-Mondragon","year":"2007","journal-title":"J Rheumatol"},{"key":"2021122708534466800_b42","volume-title":"Important changes to the childhood immunisation programme","author":"Department of Health","year":"2006"},{"key":"2021122708534466800_b43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tem.2007.03.004","article-title":"Defects in growth hormone receptor signaling","volume":"18","author":"Rosenfeld","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"2021122708534466800_b44","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity","volume":"38","author":"Doffinger","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2009.03881.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/156\/2\/271\/41925585\/j.1365-2249.2009.03881.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/156\/2\/271\/41925585\/j.1365-2249.2009.03881.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:24:46Z","timestamp":1641054286000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/156\/2\/271\/6425490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,19]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,2,19]]},"published-print":{"date-parts":[[2009,4,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2009.03881.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,5]]},"published":{"date-parts":[[2009,2,19]]}}}